Frank Leonard
About Frank Leonard
Frank Leonard is the EVP & President of Novocure Oncology and serves on the board of the Medical Device Manufacturers Association. He has held various executive roles at Novocure and has a background in finance and business development.
Current Role at Novocure
Frank Leonard currently holds the position of EVP & President Novocure Oncology. In this role, he is responsible for overseeing the oncology segment of Novocure's business operations. His responsibilities include leading strategic initiatives and ensuring the successful implementation of oncology services and products.
Board Membership at MDMA
Frank Leonard is currently serving as a Board Member at the Medical Device Manufacturers Association (MDMA). In this capacity, he contributes to the association's mission of representing and advocating for the medical device industry, with a focus on promoting innovation and ensuring patient access to advanced medical technology.
Leadership in CNS Cancers at Novocure
In addition to his role as EVP & President Novocure Oncology, Frank Leonard also serves as President CNS Cancers U.S. at Novocure. Under his leadership, the company strategizes and implements treatments targeting central nervous system cancers, aiming to improve patient outcomes in this critical area of healthcare.
Past Experience at Novocure
Frank Leonard has accumulated extensive experience over several roles at Novocure, including Chief Development Officer from 2020 to 2022, SVP Corporate Strategy and Health Policy from 2018 to 2020, and Vice President of Financial Planning and Business Development from 2013 to 2016. His earlier roles include Senior Director of Financial Planning & Business Development and Director of Commercial Operations.
Educational Background
Frank Leonard holds a Master’s Degree from The London School of Economics and Political Science (LSE) earned in 2004, as well as a Bachelor’s Degree from Harvard University, where he studied from 1997 to 2001. His solid academic background laid the foundation for his career in financial planning, corporate strategy, and healthcare investments.